Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 7 | 2022 | 37 | 4.270 |
Why?
|
| Quercetin | 4 | 2016 | 10 | 2.090 |
Why?
|
| Antineoplastic Agents | 3 | 2022 | 61 | 1.780 |
Why?
|
| Tea | 3 | 2016 | 7 | 1.580 |
Why?
|
| Furans | 2 | 2020 | 5 | 1.270 |
Why?
|
| Lignans | 2 | 2020 | 5 | 1.270 |
Why?
|
| Taxoids | 2 | 2016 | 6 | 1.100 |
Why?
|
| Cell Proliferation | 6 | 2020 | 110 | 1.070 |
Why?
|
| Tumor Burden | 2 | 2020 | 15 | 0.890 |
Why?
|
| Male | 7 | 2022 | 1649 | 0.810 |
Why?
|
| Receptors, CCR2 | 1 | 2020 | 6 | 0.760 |
Why?
|
| Chemokine CCL2 | 1 | 2020 | 12 | 0.760 |
Why?
|
| Inflammation | 1 | 2020 | 44 | 0.740 |
Why?
|
| Adipose Tissue | 1 | 2020 | 42 | 0.730 |
Why?
|
| Cell Line, Tumor | 6 | 2020 | 138 | 0.720 |
Why?
|
| Polyphenols | 2 | 2016 | 4 | 0.700 |
Why?
|
| Humans | 8 | 2022 | 2493 | 0.680 |
Why?
|
| Obesity | 1 | 2020 | 102 | 0.670 |
Why?
|
| Animals | 5 | 2022 | 1238 | 0.540 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 25 | 0.450 |
Why?
|
| Receptors, Androgen | 3 | 2020 | 33 | 0.440 |
Why?
|
| Apoptosis | 3 | 2022 | 162 | 0.420 |
Why?
|
| Drug Synergism | 3 | 2016 | 24 | 0.410 |
Why?
|
| Mice | 3 | 2020 | 508 | 0.400 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 12 | 0.380 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 118 | 0.310 |
Why?
|
| STAT3 Transcription Factor | 2 | 2017 | 21 | 0.280 |
Why?
|
| Mice, SCID | 2 | 2016 | 6 | 0.270 |
Why?
|
| Phytochemicals | 1 | 2022 | 4 | 0.230 |
Why?
|
| Hormones | 1 | 2022 | 12 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 1 | 2022 | 21 | 0.220 |
Why?
|
| Exosomes | 1 | 2022 | 6 | 0.210 |
Why?
|
| Neoplasms | 1 | 2022 | 54 | 0.200 |
Why?
|
| Adipokines | 1 | 2020 | 3 | 0.190 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 9 | 0.190 |
Why?
|
| Prostate | 1 | 2020 | 10 | 0.190 |
Why?
|
| Administration, Oral | 1 | 2020 | 19 | 0.190 |
Why?
|
| Adipocytes | 1 | 2020 | 26 | 0.190 |
Why?
|
| Cytokines | 1 | 2020 | 47 | 0.180 |
Why?
|
| Transcription Factors | 1 | 2020 | 42 | 0.180 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 143 | 0.180 |
Why?
|
| Diet, High-Fat | 1 | 2020 | 54 | 0.180 |
Why?
|
| MicroRNAs | 2 | 2022 | 41 | 0.180 |
Why?
|
| Pyrans | 1 | 2017 | 4 | 0.150 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 6 | 0.150 |
Why?
|
| Telomerase | 1 | 2017 | 8 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 21 | 0.150 |
Why?
|
| Plant Extracts | 1 | 2016 | 6 | 0.140 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 32 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 77 | 0.140 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2015 | 7 | 0.130 |
Why?
|
| Catechin | 1 | 2015 | 4 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 25 | 0.130 |
Why?
|
| Androgens | 1 | 2014 | 29 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2015 | 52 | 0.130 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2013 | 2 | 0.120 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2013 | 2 | 0.120 |
Why?
|
| Chemoprevention | 1 | 2013 | 5 | 0.120 |
Why?
|
| Signal Transduction | 1 | 2014 | 180 | 0.120 |
Why?
|
| Ligands | 1 | 2022 | 15 | 0.050 |
Why?
|
| Models, Biological | 1 | 2022 | 43 | 0.050 |
Why?
|
| HT29 Cells | 1 | 2017 | 9 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 14 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 14 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 35 | 0.040 |
Why?
|
| beta Catenin | 1 | 2017 | 16 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 28 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2017 | 21 | 0.040 |
Why?
|
| Benzamides | 1 | 2017 | 13 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 26 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 24 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2017 | 68 | 0.040 |
Why?
|